Stockscreener 앱 받기
41.01
2.07%
0.83
시장 영업 전:
42.73
1.72
+4.19%
전일 마감가:
$40.18
열려 있는:
$42.5
하루 거래량:
54,866
Relative Volume:
0.73
시가총액:
$1.99B
수익:
$32.72M
순이익/손실:
$-27.55M
주가수익비율:
-71.72
EPS:
-0.5718
순현금흐름:
$-41.40M
1주 성능:
-20.37%
1개월 성능:
+27.38%
6개월 성능:
+95.94%
1년 성능:
+1,021%
1일 변동 폭
$40.81
$42.88
1주일 범위
$38.89
$51.03
52주 변동 폭
$3.81
$57.14
나노바이오틱스 Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
41.01 | 1.95B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
나노바이오틱스 Stock (NBTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-06 | 개시 | TD Cowen | Buy |
| 2024-08-28 | 개시 | Guggenheim | Buy |
| 2023-12-08 | 개시 | Leerink Partners | Outperform |
| 2021-01-06 | 개시 | Evercore ISI | Outperform |
나노바이오틱스 주식(NBTX)의 최신 뉴스
NBTX Stock Price, Quote & Chart | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering - GlobeNewswire Inc.
XP posts downbeat Q1 earnings, joins Akamai Technologies and other big stocks moving lower in Tuesday's pre-market session - MSN
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's P - Benzinga
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer - ChartMill
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpStill a Buy? - MarketBeat
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - ChartMill
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 7.2% HigherShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - ChartMill
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Trading Up 3.3% – Time to Buy? - Defense World
나노바이오틱스 (NBTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.98%
1.33%
자본화:
|
볼륨(24시간):